Day One Biopharmaceuticals Inc (DAWN) USD0.0001
1.26%- This stock can be held in a
Stocks and Shares ISASell:$7.72
Buy:$7.74
Change:
$0.16
(2.03%)
$0.16
(2.03%)Market closed | Prices delayed by at least 15 minutes
Sell:$7.72
Buy:$7.74
Change:$0.16
(2.03%)
$0.16
(2.03%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 February 2025 | Charles N II YorkCFO | Sell Tax related | 4,370 | $11.96 | $52,278.31 | 252,638 |
| 18 February 2025 | Jeremy BenderPresident/CEO | Sell Tax related | 12,048 | $11.96 | $144,130.22 | 128,015 |
| 18 February 2025 | Adam DubowGeneral Counsel | Sell Tax related | 4,646 | $11.96 | $55,580.10 | 39,602 |
| 10 December 2024 | Samuel C BlackmanHead of Division | Sell Regular sell transaction (market) | 30,000 | $13.31 | $399,339.00 | 1,034,015 |
| 18 November 2024 | Samuel C BlackmanHead of Division | Sell Tax related | 2,206 | $13.21 | $29,141.70 | 1,064,015 |
| 18 November 2024 | Charles N II YorkCFO | Sell Tax related | 2,602 | $13.21 | $34,372.94 | 240,133 |
| 18 November 2024 | Jeremy BenderPresident/CEO | Sell Tax related | 10,554 | $13.21 | $139,420.45 | 108,377 |
| 18 November 2024 | Adam DubowGeneral Counsel | Sell Tax related | 3,165 | $13.21 | $41,810.28 | 32,162 |
| 11 November 2024 | Samuel C BlackmanHead of Division | Sell Regular sell transaction (market) | 10,000 | $16.10 | $160,994.00 | 1,057,535 |
| 8 November 2024 | Samuel C BlackmanHead of Division | Sell Regular sell transaction (market) | 18,255 | $16.17 | $295,228.99 | 1,067,535 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 1 August 2024 | AI DAY 1 LLC10% Owner | Buy Regular purchase transaction | 827,586 | $14.50 | $11,999,914.24 | 827,586 |
| 1 May 2024 | Jeremy BenderPresident/CEO | Sell Regular sell transaction (market) | 70,051 | $17.88 | $1,252,182.64 | 651,762 |
| 1 May 2024 | Charles N II YorkCFO | Sell Regular sell transaction (market) | 52,183 | $17.89 | $933,397.32 | 225,571 |
| 10 September 2024 | Samuel C BlackmanHead of Division | Sell Regular sell transaction (market) | 30,000 | $14.22 | $426,675.00 | 1,097,535 |
| 10 December 2024 | Samuel C BlackmanHead of Division | Sell Regular sell transaction (market) | 30,000 | $13.31 | $399,339.00 | 1,034,015 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.